from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3733c/-

LFCtreatmentdescriptionclass of inhibitor

0.534

Amikacinug/mL Amikacintranslation

-0.182

Cap5-10ug/mL Capreomycintranslation

-0.779

Rox10-50 ug/mL Roxithromycintranslation

0.950

SM2-5 ug/mL Streptomycintranslation

-1.507

Tet5-10 ug/mL Tetracyclinetranslation

-0.338

Rif0.2-5ug/mL Rifampicintranscription

0.014

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.671

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.442

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.370

CPZ10-50 ug/mL Chlorpromazinerespiration

1.292

Clofazimine10-13 ug/mL Clofaziminerespiration

0.595

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.089

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.710

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.459

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.716

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.789

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.511

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.239

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.205

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.076

KCN5-20 ug/mL Potassium cyaniderespiration

-0.269

NaN30.2-2 mM Sodium aziderespiration

1.368

Nigericin50 uM Nigericinrespiration

0.904

TRC10-150 ug/mL Triclosanrespiration

0.295

TRZ10-25 ug/mL Thioridazinerespiration

-1.586

Valinomycin0.5-10 uM Valinomycinrespiration

0.624

ZnSO42 mM ZnSO4respiration

-1.007

menadione6-10 ug/mL Menadionerespiration

0.451

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.169

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.943

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.113

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.020

NRP_1Non-replicating persistence stage 1dosRassociated

0.521

Amp0.2mg/mL AmpicillincellWall

-0.254

Cephalexin20-100 ug/mL CephalexincellWall

-0.182

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.004

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.452

EMB10-20 ug/mL EthambutolcellWall

0.445

Eta12-40 ug/mL EthionamidecellWall

1.124

INH0.2-0.4 ug/mL IsoniazidcellWall

0.097

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.156

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.482

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.017

BZA0.12 mg/mL BenzamidearomaticAmides

-0.469

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.676

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.802

H2O24 mM hydrogen peroxideDNAdamaging

0.685

Levo10 ug/mL LevofloxacinDNAdamaging

-0.590

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.872

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.483

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.287

UVUV-irradiationDNAdamaging

-1.254

ARP41-4 ug/mL Antitubercular compound ARP4?

0.200

Antimycin12.5-50 ug/mL Antimycin A?

0.428

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.001

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.616

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.092

PA8240.2-2 ug/mL PA-824?

-1.125

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.265

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.005

Verapamil50 uM Verapamil?

0.906

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.290

methoxatin10-20 ug/mL Methoxatin?